Stifel raises Ionis Pharmaceuticals stock price target to $67 from $43

Investing.comMonday, October 6, 2025 at 2:11:18 PM
Stifel raises Ionis Pharmaceuticals stock price target to $67 from $43
Stifel has raised its price target for Ionis Pharmaceuticals from $43 to $67, reflecting a positive outlook on the company's future performance. This adjustment indicates confidence in Ionis's growth potential and could attract more investors, highlighting the company's advancements in drug development and market position.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Stifel reiterates Buy rating on Gambling.com stock, maintains $15 target
PositiveFinancial Markets
Stifel has reaffirmed its Buy rating on Gambling.com stock, maintaining a target price of $15. This is significant as it reflects confidence in the company's growth potential in the online gambling sector, which continues to expand rapidly. Investors may find this a promising opportunity, especially as the market evolves and more states legalize online gambling.
Stifel reiterates Datadog stock Hold rating amid OpenAI contract renewal
NeutralFinancial Markets
Stifel has maintained its Hold rating on Datadog's stock as the company navigates the renewal of its contract with OpenAI. This decision reflects a cautious approach amid ongoing developments in the tech sector. Investors are keenly watching how this contract renewal will impact Datadog's performance and market position, making it a significant point of interest for those involved in tech investments.
Stifel reiterates Buy rating on Okta stock, maintains $130 price target
PositiveFinancial Markets
Stifel has reaffirmed its Buy rating on Okta's stock and is maintaining a price target of $130. This is significant as it reflects confidence in Okta's growth potential and market position, which could encourage investors to consider the stock as a viable option for their portfolios.
Stifel raises Alnylam Pharmaceuticals stock price target to $495 on strong Vutrisiran sales
PositiveFinancial Markets
Stifel has raised its price target for Alnylam Pharmaceuticals to $495, driven by strong sales of Vutrisiran. This increase reflects confidence in the company's growth and the effectiveness of its products, which is great news for investors and the market. As Vutrisiran continues to perform well, it highlights Alnylam's position in the pharmaceutical industry and its potential for future success.
IsoEnergy stock rating resumed at Buy by Stifel on dual-market strategy
PositiveFinancial Markets
IsoEnergy has received a positive boost as Stifel has resumed its stock rating at 'Buy', highlighting the company's dual-market strategy. This is significant because it reflects confidence in IsoEnergy's potential for growth and profitability, especially in a competitive market. Investors may see this as a strong indicator of the company's future performance.
Latest from Financial Markets
France in fresh political and market turmoil after prime minister resigns
NegativeFinancial Markets
France is facing new political and market instability following the resignation of Prime Minister Sébastien Lecornu. His departure has prompted President Emmanuel Macron to urgently seek a stability plan, highlighting the ongoing challenges in the French government. This situation is significant as it could impact economic policies and public confidence, making it crucial for the administration to act swiftly to restore stability.
U.S. Warehouse Vacancies Steady as Demand Rises With Less New Space
NeutralFinancial Markets
In the third quarter, the U.S. warehouse vacancy rate remained stable at an 11-year high, marking a significant shift as it did not increase for the first time in three years. This stability comes amidst rising demand for warehouse space, even as the construction of new facilities continues to decline. This trend is important as it reflects the changing dynamics in the logistics and supply chain sectors, indicating a potential shift in how businesses are managing their storage needs.
Mexico intercepts new screwworm case in northern border state
NeutralFinancial Markets
Mexico has reported a new case of screwworm in a northern border state, prompting authorities to take immediate action to prevent its spread. This invasive pest poses a significant threat to livestock and agriculture, making it crucial for the government to monitor and control the situation. The detection of this case highlights the ongoing challenges faced by the agricultural sector in managing pests that can impact food security and animal health.
Mears buys Kayne Anderson (KYN) shares worth $122,365
PositiveFinancial Markets
Mears has made a strategic move by purchasing shares worth $122,365 in Kayne Anderson, signaling confidence in the company's future. This acquisition is significant as it reflects Mears' commitment to expanding its investment portfolio and could lead to potential growth opportunities. Investors and market watchers will be keen to see how this decision impacts both companies moving forward.
Evercore's Schlosstein on Shutdown; OpenAI, AMD Partnership | Bloomberg Markets 10/6/2025
NeutralFinancial Markets
In a recent episode of Bloomberg Markets, Evercore's Ralph Schlosstein discussed the current market landscape, touching on the implications of a potential government shutdown. The conversation also highlighted the partnership between OpenAI and AMD, showcasing how these collaborations could influence technology and finance. This matters as it provides insights into how major players are navigating economic uncertainties and leveraging partnerships to drive innovation.
Paramount Buys Bari Weiss’s the Free Press for $150 Million
PositiveFinancial Markets
Paramount's acquisition of Bari Weiss's the Free Press for $150 million marks a significant shift in media ownership, as Weiss, a prominent figure who previously distanced herself from traditional media, now aims to reshape CBS News's editorial direction. This move is important because it signals a commitment to delivering news that resonates with audiences and reflects the complexities of reality, potentially influencing how news is reported and consumed.